Published in Medical Letter on the CDC and FDA, August 26th, 2007
The U.S. District Court for the District of Columbia ruled in December 2005 that the "Prescription Drug Excessive Pricing Act of 2005" was preempted by federal patent laws and therefore unconstitutional. The presiding judge, Richard Leon, stated in his ruling that Congress sought to "encourage and reward the innovation, research, and development of new drugs" and that the Act did not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.